Procter & Gamble, US7427181091

Procter & Gamble stock at EUR 134.22, market cap USD 357.7 billion

Published on 10/08/2026 at 20:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evercore set a USD 166.00 target on October 6, 2026. Procter & Gamble stock costs EUR 134.22 on October 8, 2026, up 1.45 percent.

Key points in brief

  • Procter & Gamble stock was EUR 134.22 at Lang & Schwarz on October 8, 2026, up 1.45 percent from the prior close.
  • The company had a USD 357.7 billion market capitalization and a 22.73 P/E ratio as of October 8, 2026.
  • Evercore raised its Procter & Gamble target from USD 161.00 to USD 166.00 on October 6, 2026.
  • Fiscal first-quarter 2027 results are scheduled for October 22, 2026.
Schwarzweiß-Fabrikaufnahme: Arbeiter verpacken unbeschriftete Kartons am Fließband
Schwarzweiß-Reportage aus Fabrik zeigt Produktion der The Procter & Gamble Company, ISIN US7427181091, dokumentarisch, Illustration mit AI erstellt.

Procter & Gamble stock was trading at EUR 134.22 at Lang & Schwarz on October 8, 2026, at 8:03 p.m. CEST, up 1.45 percent versus the prior close of EUR 132.30. The euro quotation puts the stock above its previous session level while the US market remains the main valuation reference.

After-hours quote reaches EUR 134.22

The Lang & Schwarz bid was EUR 134.20 and the ask was EUR 134.24 on October 8, 2026. On the NYSE, the stock was last at USD 150.48 at 2:06 p.m. ET on the same date, up 1.80 percent from USD 147.82.

Yearly range leaves a 10.03 percent gap

The NYSE 52-week range stood at USD 137.62 to USD 167.25 on October 8, 2026. At USD 150.48, the stock was 10.03 percent below its 52-week high, leaving the range as a direct measure of its position rather than a forecast.

The current market capitalization was USD 357.7 billion, while the trailing P/E ratio was 22.73 and the dividend yield was 3.00 percent on October 8, 2026. Those figures place valuation and income alongside the daily price move.

Analyst target sits 10.31 percent higher

As CNBC reported on October 6, 2026, Evercore ISI upgraded Procter & Gamble from In Line to Outperform and raised its price target from USD 161.00 to USD 166.00. The new target was 10.31 percent above the NYSE price of USD 150.48 on October 8, 2026.

Comparison with peers

Procter & Gamble: plus 1.45 percent, P/E 22.73, market capitalization USD 357.7 billion

Colgate-Palmolive (NYSE, USD): plus 1.22 percent, P/E 34.97, market capitalization USD 70.6 billion

Kimberly-Clark (NYSE, USD): plus 1.31 percent, P/E 16.62, market capitalization USD 32.4 billion

Results date set for October 22

According to Gekko on September 30, 2026, Procter & Gamble is scheduled to report fiscal first-quarter 2027 results on October 22, 2026, before the US market opens. The date gives the valuation figures a defined near-term reference point.

Price and valuation in context

Procter & Gamble's euro price, its USD 357.7 billion market capitalization and its 22.73 P/E ratio describe a large, established consumer-products company trading above Kimberly-Clark's multiple but below Colgate-Palmolive's multiple. The next results date will put the focus on sales, margins and the full-year outlook.

The further course of trading is shown by the continuously updated real-time quote of Procter & Gamble stock.

Procter & Gamble stock facts

  • Company: The Procter & Gamble Company
  • ISIN: US7427181091
  • Ticker: PG
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 8, 2026, 8:03 p.m. CEST): EUR 134.22
  • Change versus prior close: plus 1.45 percent
  • Prior close Lang & Schwarz (October 7, 2026): EUR 132.30
  • Market capitalization: USD 357.7 billion (as of October 8, 2026)
  • 52-week range: USD 137.62-167.25 (as of October 8, 2026)
  • Sector / Industry: Consumer Defensive / Household and Personal Products
  • Next earnings date: October 22, 2026

Market context: Market report S&P 500.

More news and analyses on Procter & Gamble stock

Disclaimer...

en | US7427181091 | PROCTER & GAMBLE | boerse | 70269700 | bgmi